MET Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MetLife Inc (MET) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows stable technical indicators, positive sentiment from Congress trading data, and favorable analyst ratings with upward price target revisions. Despite hedge fund selling, the stock's fundamentals and long-term growth potential make it a solid choice for this investor profile.
The stock's technical indicators show mixed signals. The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 47.353, suggesting no clear overbought or oversold conditions. However, moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near a key support level (S1: 83.951), which could provide a good entry point.
Congress trading data shows a recent purchase transaction with a median amount of $0.8M, indicating confidence from influential figures.
Analysts have consistently raised price targets, with multiple firms maintaining Outperform or Buy ratings.
Bullish moving averages and proximity to support levels suggest potential for upward movement.
Hedge funds are selling the stock, with a significant increase in selling activity (119940.49%).
MACD is negative and expanding, indicating short-term bearish momentum.
The stock has underperformed in the regular and post-market sessions, with a combined decline of 0.84%.
Financial data for the latest quarter is unavailable. However, analysts have raised estimates and price targets based on favorable Q1 results and improved underwriting performance.
Analyst sentiment is positive, with multiple firms raising price targets recently. Piper Sandler raised the target to $86, Keefe Bruyette to $98, Wells Fargo to $95, and JPMorgan to $96. Most analysts maintain Outperform or Overweight ratings, reflecting confidence in the stock's long-term potential.
